Krishnan Harinivas Harshan

This study identifies Snail as a host restriction factor that limits SARS-CoV-2 entry by reducing ACE2 expression through transcriptional regulation and translational suppression.

This study shows STING restricts JEV replication and drives inflammatory responses through NLRP3 inflammasome activation and pyroptosis.

This study shows Musashi1 interacts with SARS-CoV-2 RNA, represses viral translation, and reduces infection in intestinal cells.

The paper shows that DDX39A interaction with RNA reduces α-Synuclein amyloid formation, while viral rG4s enhance it, linking RNA dynamics to Parkinson's disease pathogenesis.

This study identifies MAVS as a mitochondrial guardian that maintains mitochondrial integrity to drive IFN-independent antiviral immunity against SARS-CoV-2 and JEV.

This study identifies FDA-approved drugs that bind G-quadruplexes in SARS-CoV-2 genomes, showing significant inhibition of viral replication in hamsters and cell cultures comparable to Remdesivir.

The paper develops an inexpensive RT-nPCR assay for SARS-CoV-2 that matches RT-qPCR performance and highlights low detection efficiency in real-world RT-qPCR testing.

This paper simplifies and improves SARS-CoV-2 detection by removing the RNA isolation step in RT-PCR, making it faster, cheaper, and more efficient without sacrificing accuracy.